-
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa
26 Jun 2025 07:03 GMT
… ) — For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical …
-
Cell-based, gene therapy skin grafts heal large epidermolysis bullosa wounds
24 Jun 2025 22:38 GMT
… chronic wounds for patients with epidermolysis bullosa.
The technology could be the … in patients with recessive dystrophic epidermolysis bullosa, according to study results published … in The Lancet.
“Epidermolysis bullosa (EB) is a family of …
-
Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa
24 Jun 2025 11:30 GMT
… pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). This article, … Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa Wounds (VIITAL): A … patients with recessive dystrophic epidermolysis bullosa (RDEB). Important Safety …
-
Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis Bullosa
24 Jun 2025 11:00 GMT
… of corneal abrasions in dystrophic epidermolysis bullosa (DEB) patients. KB803 is designed … of eye pain and monthly Epidermolysis Bullosa Eye Disease Index (EB-EDI … for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing …
-
Stanford Medicine-led phase 3 trial shows gene therapy skin grafts help epidermolysis bullosa
24 Jun 2025 02:44 GMT
… The grafts treat severe dystrophic epidermolysis bullosa, or EB, a genetic … as butterfly wings
Severe dystrophic epidermolysis bullosa is very rare, affecting …
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two- …
-
Assessing Quality of Life in Patients with Epidermolysis Bullosa in the Saudi Population: Validation of the QOLEB Questionnaire
19 Jun 2025 17:34 GMT
… of the Epidermolysis Bullosa Simplex (EBS) type; Dystrophic Epidermolysis Bullosa (DEB) and Junctional Epidermolysis Bullosa (JEB … usually refers to “inherited epidermolysis bullosa” (or “hereditary epidermolysis bullosa”), and the condition is …
-
Dermaliq and DEBRA partner to advance epidermolysis bullosa drug delivery
04 Jun 2025 11:42 GMT
… delivery into the skin for epidermolysis bullosa (EB).
The non-exclusive collaboration …
-
New DEBRA-Dermaliq Collaboration Targets Enhanced Drug Delivery for Epidermolysis Bullosa
28 May 2025 15:09 GMT
… advance cutaneous drug delivery for epidermolysis bullosa. News release. Globe Newswire. … Advance-Cutaneous-Drug-Delivery-for-Epidermolysis-Bullosa.html
Mellerio JE, Kiritsi D … burden of severe forms of epidermolysis bullosa - Implications for patient …
-
DEBRA Research and Dermaliq Enter into a Strategic Collaboration to Advance Cutaneous Drug Delivery for Epidermolysis Bullosa
28 May 2025 07:00 GMT
… prophylactic therapies for people with Epidermolysis Bullosa.
Dermaliq’s proprietary hyliQ® technology … development for those affected by Epidermolysis Bullosa (EB), and Dermaliq Therapeutics, Inc …
-
Relief Therapeutics’ RLF-TD011 receives US FDA rare paediatric disease designation for treatment of epidermolysis bullosa
24 May 2025 11:13 GMT
… to meaningfully advance epidermolysis bullosa wound care by … of epidermolysis bullosa was sold for $155 million.
Epidermolysis bullosa … s layers: epidermolysis bullosa simplex, dystrophic epidermolysis bullosa, junctional epidermolysis bullosa and Kindler …
About
© 1995-2025